Skip to content

Pulsed Field Ablation therapeutic apparatus for atrial fibrillation

Pulsed Field Ablation therapeutic apparatus for atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062157
Enrollment
Unknown
Registered
2022-07-26
Start date
2022-07-12
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

PFA group:PFA ablation

Sponsors

Tianjin first central hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Between 18 and 75 years old (including 18 and 75 years old), regardless of gender; 2.Patients with clinical definite diagnosis of atrial fibrillation; 3.The subjects understood the test process and voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Left ventricular ejection fraction (LVEF) = 40%; 2.Cardiac function: NYHA class ? - ?; 3.Previous unsuccessful radiofrequency ablation or recurrent cases; 4.Pregnant and lactating women and those who plan to become pregnant within one year; 5.Those with obvious bleeding tendency or suffering from blood system diseases and unable to tolerate anticoagulant drugs; 6.Acute or severe systemic infection, clinically significant severe liver and kidney dysfunction, uncontrolled hyperthyroidism Or patients with malignant tumors and end-stage diseases; 7.Before operation, it was confirmed that there were many types of tachyarrhythmias; 8.Severe organic cardiovascular disease; 9.Stroke and other cerebrovascular diseases in recent 3 months, 10.Thromboembolic disease; 11.Patients with mental abnormality or history of mental illness who cannot cooperate autonomously, and patients with history of epilepsy; 12.Severe allergic constitution; 13.Those who have participated in clinical trials of any drugs and / or medical devices within 1 month before enrollment; 14.The researchers believe that there are any other factors that are not suitable for inclusion or affect the subjects' participation in the study.

Design outcomes

Primary

MeasureTime frame
Immediate success rate: pulmonary vein isolation after ablation;ECG;

Countries

China

Contacts

Public ContactLu chengzhi
5020200072@nankai.edu.cn13512967656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026